Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP440804.RAYEDsXtnzOajYdmPFvLN8FgIo1yuaOE4HcONJIM-TBw4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP440804.RAYEDsXtnzOajYdmPFvLN8FgIo1yuaOE4HcONJIM-TBw4130_assertion type Assertion NP440804.RAYEDsXtnzOajYdmPFvLN8FgIo1yuaOE4HcONJIM-TBw4130_head.
- NP440804.RAYEDsXtnzOajYdmPFvLN8FgIo1yuaOE4HcONJIM-TBw4130_assertion description "[These data suggest that the bipartite GEF, ELMO1 and Dock180, play an important role in promoting cancer cell invasion and could be potential therapeutic targets for the treatment of diffuse malignant gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440804.RAYEDsXtnzOajYdmPFvLN8FgIo1yuaOE4HcONJIM-TBw4130_provenance.
- NP440804.RAYEDsXtnzOajYdmPFvLN8FgIo1yuaOE4HcONJIM-TBw4130_assertion evidence source_evidence_literature NP440804.RAYEDsXtnzOajYdmPFvLN8FgIo1yuaOE4HcONJIM-TBw4130_provenance.
- NP440804.RAYEDsXtnzOajYdmPFvLN8FgIo1yuaOE4HcONJIM-TBw4130_assertion SIO_000772 17671188 NP440804.RAYEDsXtnzOajYdmPFvLN8FgIo1yuaOE4HcONJIM-TBw4130_provenance.
- NP440804.RAYEDsXtnzOajYdmPFvLN8FgIo1yuaOE4HcONJIM-TBw4130_assertion wasDerivedFrom befree-20140225 NP440804.RAYEDsXtnzOajYdmPFvLN8FgIo1yuaOE4HcONJIM-TBw4130_provenance.
- NP440804.RAYEDsXtnzOajYdmPFvLN8FgIo1yuaOE4HcONJIM-TBw4130_assertion wasGeneratedBy ECO_0000203 NP440804.RAYEDsXtnzOajYdmPFvLN8FgIo1yuaOE4HcONJIM-TBw4130_provenance.